This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Primary Antibodies
Boster offers high-affinity primary antibodies both monoclonal and polyclonal. Boster's primary antibodies are well cited over the past 25+ years and have continued to be trusted by the research community. You can find here antibodies thoroughly validated on Western Blotting, Immunohistochemistry, and ELISA.
Product Categories
Anti-NUBP1 Antibody Picoband™ (A08538-1)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA Flow Cytometry IF ICC WB |
Anti-MGAT3 Antibody Picoband™ (A08470-1)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA IHC WB |
Anti-NELF/NSMF Antibody Picoband™ (A08385-1)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human, Mouse, Rat |
| Application: | ELISA Flow Cytometry IHC WB |
Anti-NPFFR2 Antibody Picoband™ (A08389-2)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA WB |
Anti-PFKFB1 Antibody Picoband™ (A08398-2)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA Flow Cytometry IHC WB |
Anti-PLEKHG5 Antibody Picoband™ (A08522)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA IF IHC ICC WB |
Anti-SULF2 Antibody Picoband™ (A03903-2)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA WB |
Anti-OSBPL8 Antibody Picoband™ (A08408-2)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA Flow Cytometry IF ICC WB |
Anti-RREB1 Antibody Picoband™ (A03902-2)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA Flow Cytometry WB |
Anti-OLAH Antibody Picoband™ (A05069-3)
| Price: | $370 |
|---|---|
| Size: | 100 µg/vial |
| Reactivity: | Human |
| Application: | ELISA Flow Cytometry IF ICC WB |